Evox Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Evox Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11102
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evox Therapeutics Ltd (Evox Therapeutics) is a biotechnology company focused on harnessing and engineering the natural delivery capabilities of exosomes, to develop novel medicines for various diseases. Its development pipeline is focused in the therapeutic areas of inflammatory, immune diseases, and neuroscience. Evox Therapeutics harnesses its proprietary EV-based drug delivery technology using advanced biomolecular engineering, technology and drug loading strategies to deliver protein biologics, antibody and nucleic acid-based drugs to tissues and organs including the brain and central nervous system. The company works in collaboration with various other research universities such as Karolinska Institutet, Harvard Medical School and Ludwig Maximilian University Munich. The company is a spin off from Oxford University. Evox Therapeutics is headquartered in Oxford, the UK.

Evox Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Evox Therapeutics Raises USD46 Million in Series B Financing 10
Evox Therapeutics Raises USD14.4 Million in Seed Financing Round 12
Partnerships 13
Evox Therapeutics Enters into Research Agreement with Boehringer Ingelheim 13
Equity Offering 14
Evox Therapeutics Spin-Off from University of Oxford 14
Evox Therapeutics Ltd – Key Competitors 15
Evox Therapeutics Ltd – Key Employees 16
Evox Therapeutics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Apr 26, 2018: Evox Therapeutics Expands Into New Facilities at the Oxford Science Park 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evox Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Evox Therapeutics Raises USD46 Million in Series B Financing 10
Evox Therapeutics Raises USD14.4 Million in Seed Financing Round 12
Evox Therapeutics Enters into Research Agreement with Boehringer Ingelheim 13
Evox Therapeutics Spin-Off from University of Oxford 14
Evox Therapeutics Ltd, Key Competitors 15
Evox Therapeutics Ltd, Key Employees 16
Evox Therapeutics Ltd, Other Locations 17

List of Figures
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evox Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Evox Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lloyds Banking Group Plc:企業のM&A・事業提携・投資動向
    Lloyds Banking Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lloyds Banking Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Brembo SpA:企業の戦略・SWOT・財務情報
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Husky Energy Inc:企業の戦略・SWOT・財務情報
    Husky Energy Inc - Strategy, SWOT and Corporate Finance Report Summary Husky Energy Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ONEOK, Inc.:企業の戦略・SWOT・財務情報
    ONEOK, Inc. - Strategy, SWOT and Corporate Finance Report Summary ONEOK, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Infratil Ltd (IFT)-エネルギー分野:企業M&A・提携分析
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • NovaDigm Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, vaccine clinical supplies, ALS3 vaccines, bacterial and fungal vaccine antigens, fungal a …
  • MedMira Inc (MIR):企業の財務・戦略的SWOT分析
    Summary MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the …
  • Hirose Electric Co Ltd (6806):企業の財務・戦略的SWOT分析
    Hirose Electric Co Ltd (6806) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • NanoPass Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and commercializes intradermal delivery solutions for vaccines and drugs. The company's product include MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its micronjet microneed …
  • Diagnostics For All Inc:企業の製品パイプライン分析2018
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • African Development Bank Group:電力:M&Aディール及び事業提携情報
    Summary African Development Bank Group (AfDB) is a development finance institution. It promotes social and economic development by providing loans, grants, guarantees, equity investments and technical assistance in its regional member countries. The constituent institutions of the bank include The A …
  • Lianhe Chemical Technology Co., Ltd. (002250):企業の財務・戦略的SWOT分析
    Lianhe Chemical Technology Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Nisshin Seifun Group Inc:企業の戦略・SWOT・財務分析
    Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hitachi Koki Co., Ltd.:企業の戦略的SWOT分析
    Hitachi Koki Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Centrica Plc (CNA):企業の財務・戦略的SWOT分析
    Centrica Plc (CNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vericel Corp (VCEL):医療機器:M&Aディール及び事業提携情報
    Summary Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts fo …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology engaged in the development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products which include MGN1601, and others. It also engaged in developing EnanDIM product to treat antitumor efficacy by stimulatin …
  • Mesa Laboratories Inc (MLAB):企業の財務・戦略的SWOT分析
    Summary Mesa Laboratories Inc (Mesa) is a medical device company that manufactures and markets validation and monitoring instruments. The company’s products include mesa biological indicators, DryCal gas flow calibrators, BGI ambient particulate sampling, DialyGuard dialysate meters, SureTorque cap …
  • Barnwell Industries Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Barnwell Industries Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Barnwell Industries Inc (Barnwell) is a diversified company. The company's business activities include oil and natural gas, land investment, and contract drilling. Its oil and natural gas divisio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆